A computational model is presented that can be used as a tool in the design of safer chemicals. This model predicts the rate of hydrogen-atom abstraction by cytochrome P450 enzymes. Excellent correlations between biotransformation rates and the calculated activation energies (AHact) of the cytochrome P450-mediated hydrogen-atom abstractions were obtained for the in vitro biotransformation of six halogenated alkanes (1-fluoro-1,1,2,2-tetrachloroethane, 1,1-difluoro-1,2,2-trichloroethane, 1,1,1-trifluoro-2,2-dichloroethane, 1,1,1,2-tetrafluoro-2-chloroethane, 1,1,1,2,2-pentafluoroethane, and 2-bromo-2-chloro-1,1,1-trifluoroethane) with both rat and human enzyme preparations: ln(rate, rat liver microsomes) = The design of chemicals with lowest possible toxicity would decrease the damage to the environment; decrease the costs of production, health care, and site remediation; and increase the safety in the workplace (1). Although many factors are involved in the design of safer chemicals, one significant aspect is the prediction of rates of bioactivation of protoxins and procarcinogens to toxic metabolites (2). Bioactivation plays a major role in the toxicity of many chemicals, and the most important enzymes involved are the cytochromes P450 (CYPs) (2). The CYP enzymes catalyze the activation of molecular oxygen to a reactive monooxygen species (3), which can oxidize a variety of compounds (4). The transition state for the hydrogen-atom abstraction reaction is not, however, stabilized by the enzyme (3). Furthermore, the energetics of the active oxygen species is conserved among the several CYP enzymes studied (5). These factors make the CYP enzymes ideal candidates for predictive computational methods.
by humans: In [Fl peak plasma = 42.87 -1.57(AIact), r2 = 0.86.
To our knowledge, these are the first in vivo human metabolic rates to be quantitatively predicted. Furthermore, this is one of the first examples where computational predictions and in vivo and in vitro data have been shown to agree in any species. The model presented herein provides an archetype for the methodology that may be used in the future design of safer chemicals, particularly hydrochlorofluorocarbons and inhalation anesthetics.
oped as replacements for the ozone-depleting chlorofluorocarbons (6) . The metabolic fate and toxicity of H(C)FCs have been reviewed.
The energetics of the active heme-iron oxygen species of CYP has been estimated to be similar to that of a primary octyl radical (5) . In previous studies (8), we exploited this finding to refine the pioneering work of Pudzianowski and Loew (9) and established an isoenergetic surrogate, p-nitrosophenoxy radical (PNR) model, for the heme-iron oxygen species. The PNR model can be used to calculate activation energies from ground-state energies with the established free-energy relationship shown in Eq. 1 (8) : AHact = 2.60 + 0.22(AHreac) + 2.38(I.P.), [1] where AHact is the activation energy, AHreac iS the heat of reaction, and I.P. is the ionization potential of the intermediate carbon-based radical. Thus, this model depends only on ground-state energies to calculate activation energies. Previous studies on the relationship of activation energies for hydrogen-atom abstraction, calculated with this model, to the LD50 values of 26 nitriles (10) and to the amount of urinary trifluoroacetic acid formed from four H(C)FCs in rats (11) indicated that the PNR model may have the potential to predict rates of biotransformation by CYP. The present study was undertaken to test the capacity of the PNR model to predict rates of halogenated alkane biotransformation.
The design of chemicals with lowest possible toxicity would decrease the damage to the environment; decrease the costs of production, health care, and site remediation; and increase the safety in the workplace (1) . Although many factors are involved in the design of safer chemicals, one significant aspect is the prediction of rates of bioactivation of protoxins and procarcinogens to toxic metabolites (2). Bioactivation plays a major role in the toxicity of many chemicals, and the most important enzymes involved are the cytochromes P450 (CYPs) (2) . The CYP enzymes catalyze the activation of molecular oxygen to a reactive monooxygen species (3), which can oxidize a variety of compounds (4) . The transition state for the hydrogen-atom abstraction reaction is not, however, stabilized by the enzyme (3) . Furthermore, the energetics of the active oxygen species is conserved among the several CYP enzymes studied (5 Preparation of Pyridine-Induced Rat Liver Microsomes. Male Fischer 344 rats (Charles River Breeding Laboratories; 250-270 g) were given pyridine at 100 mg/kg (in 0.2 ml of saline per rat) per day for 4 consecutive days; the rats were kept on a 12-h light-and-dark cycle and were starved for 12 h before sacrifice (12) . Microsomes were prepared according to ref. 13 . Protein concentrations were measured by the method of Bradford (14) , and the CYP content was determined by CO difference spectra (15 Measurements of Biotransformation Rate. In vitro rates of biotransformation of H(C)FCs and halothane were determined by measuring end-point product formation. Incubations were carried out in Teflon-lined septum-sealed 10-ml glass vials that contained 100 mM potassium phosphate buffer (pH 7.0), liver microsomes from pyridine-induced rats at 6.2 mg of protein per ml (8.5 nmol of CYP per ml) or expressed human CYP2E1 at 366 pmol/ml, 2 mM freshly prepared NADPH, and 2 p,l of liquid substrate (HCFC-121, HCFC-122, HCFC-123, or halothane) or 5 ml of gaseous substrate (HCFC-124 or HFC-125), which was bubbled slowly into the solution through a needle while a separate needle provided pressure relief. Control incubations lacked substrate. Reactions were initiated by injecting the NADPH solution into the vials after a 5-min preincubation at 37°C and were terminated after 30 min by heating the samples at 70°C in a water bath for 5 min followed by cooling in ice for 10 min (18, 19) . Preliminary experiments were conducted to ensure that all the substrates were present at saturating concentrations and that the reaction progress was linear for at least 30 min, according to the method established by Kharasch and Thummel (20) . The samples were transferred to 1.5-ml plastic centrifuge tubes and were centrifuged for 5 min at 3000 rpm on a Sorvall RT6000 bench-top centrifuge to remove precipitated proteins. Samples of the supernatant were collected for quantification of trihaloacetic acids by gas chromatography/mass spectrometry after conversion to benzyl esters, as described above.
Calculation of Activation Energies. Activation energies for CYP-dependent hydrogen-atom abstraction reactions were calculated on the basis of the PNR model (Eq. 1). Gas (11, (21) (22) (23) (24) to be trifluoroacetic acid. The sole metabolites of HCFC-121 and HCFC-122 after incubation with liver microsomes from pyridine-induced rats or expressed human CYP2E1 in the presence of NADPH were dichlorofluoroacetic acid and chlorodifluoroacetic acid, respectively (see Materials and Methods for details).
Biotransformation Rates of Six Halogenated Alkanes. Previous studies indicated that the pyridine-inducible CYP2E1 is the predominant isoform responsible for the oxidation of small halogenated alkanes (13, 20) . Therefore, pyridine-induced rat liver microsomes were used to increase the CYP enzyme content and to facilitate the detection of acid metabolites. The biotransformation rates of five H(C)FCs and halothane were measured ( Table 1 Further experiments on the biotransformation rates of these compounds were conducted with expressed human CYP2E1 ( Table 1) . As with the microsomal preparations, the substrate with the fewest fluorines, HCFC-121, had the highest turnover rate (5.13 nmol/min per nmol of CYP) and that with the most fluorine-substituted substrate, HFC-125, had the lowest reactivity (0.067 nmol/min per nmol of CYP). The rates also span a nearly 100-fold range.
Calculation of the Activation Energies for CYP-Mediated Hydrogen-Atom Abstraction from Substrates. The heats of reaction and ionization potentials of the product radicals for a series of halogenated alkanes were calculated ( Table 2 ). The activation energies for CYP-mediated hydrogen-atom abstractions from different substrates calculated from Eq. 1 are also given in ln(rate, microsomes) = 44.99 -1.79(AHact) [2] Pharmacology: Yin et al. tThe rate of biotransformation of each compound was determined with liver microsomal mixtures from pyridine-induced rats. tThe predicted rate from a cross-validated model that does not use the predicted compound in the model. The partial least squares cross-validation analysis was carried out with the SYBYL program. §The rate of biotransformation of each compound in expressed CYP2E1 incubations (n = 4).
Eq. 3 is the equation for the line obtained for the correlation of the expressed human CYP2E1 enzyme with the activation energies calculated by the PNR model (r2 = 0.97; Fig. 1 ).
ln(rate, CYP2E1) = 46.99 -1.77(AHact) [3] Leave-one-out cross-validation was carried out to validate the predictive ability of the PNR model ( Table 1) . The cross-validated predicted rates of reaction reflect the ability of the model to predict the rate of reaction of a given compound that is not included in the model. The cross-validated r2 values were 0.71 and 0.91 for the microsomal and expressed systems, respectively, indicating that the PNR model has excellent predictive capabilities. The slopes for both enzyme systems are similar (1.79 and 1.77, respectively), pointing to similar kinetic mechanisms and energetics of the biotransformation mediated by the rat and human CYP enzymes.
Qualitative structure-activity relationships for the halogenated alkanes can be obtained from the combined experimental and computational results ( Table 2 ). Substitution at the carbon (geminal) bearing the hydrogen atom that is abstracted influences the rate of biotransformation in the order Cl > Br > F > H, whereas substitution at the adjacent position (vicinal) affects the rate in the order H > Br > Cl > F. The former reflects the combination of inductive destabilization and resonance stabilization of the forming carbon-centered radical by substituents, whereas the latter reflects inductive destabilization.
In (25, 27, 28) , and desflurane ([F-] = 0.9 AM) (30) . The activation energies were calculated as described above and are shown in Table 2 . Correlation of activation energies of the preferred oxidation site in each molecule with peak plasma fluoride concentrations gave the line shown in Eq. 4 (r2 =0.86).
ln [Fj] peak plasma = 42.87 1.57(AHact) [4] (20) , the computational model also predicts successfully the in vitro metabolic rates of these five anesthetics. Such correlations are important because these inhalation anesthetics are initially biotransformed by CYP to give fluoride (20) , and an excessive amount of fluoride causes kidney damage (31) .
To our knowledge, these are the first in vivo human metabolic rates to be quantitatively predicted. Furthermore, this is one of the first examples where computational predictions and in vivo and in vitro data have been shown to agree in any species.
The two data sets presented herein validate the PNR model as a predictive method for the CYP-mediated biotransformation of halogenated alkanes and provide an excellent quantitative structure-metabolism relationship. This relationship can be exploited in the design of safer halogenated alkanes, based on the predicted amount of metabolism to potentially toxic intermediates. For example, if two structures are under consideration for development, the compound with the lower predicted metabolic rate may be a reasonable candidate for further development, assuming that toxicity and metabolism are correlated. The relationship between metabolic rates and toxicity is discussed below.
Although these results indicate that the electronic PNR model is sufficient for predicting the metabolic rates for the halogenated alkanes, the relationship between the predicted rates of biotransformation and toxicity is less certain. For compounds that are directly biotransformed to toxic products-e.g., nitriles being converted to cyanide-biotransformation and toxicity are well correlated (10) neoantigen formation (23) . For the inhalation anesthetics presented in this study, a correlation between rate of metabolism to give fluoride and renal toxicity also exists (20) . Furthermore, 1,2-dichloro-1,1-difluoroethane (HCFC-132b) ( Table 2 ) is predicted to have relatively high biotransformation rate and has proven to be toxic (32), whereas 1,1,1,2-tetrafluoroethane (HCFC-134a) ( Table 2 ) is predicted to have low biotransformation rate and is now in commercial production and use. If, however, toxicity is associated with further biotransformation of initial products, predicted rates of biotransformation may not be correlated with toxicity. For example, 1,2-difluoroethane is metabolized to fluoroacetic acid, which is highly toxic (33) . In this instance the relative rate of biotransformation can be predicted and compared with that of a compound that does not produce fluoroacetic acid, but it would not be expected to be related to the toxicity of the two compounds. Hence the computational model can help in the design of safer chemicals, but knowledge of the underlying mechanism of toxicity of a compound and its metabolites is critical to the correct interpretation of the results.
The agreement between the predicted and experimental rates of reaction is not expected on the basis of the results of kinetic experiments on CYP-mediated reactions. It (36) have shown that water formation from the two-electron reduction of the CYPheme-iron-oxygen can unmask isotope effects in CYPcatalyzed reactions. This same effect could unmask the differences in intrinsic rates for the different halogenated hydrocarbons. ( ii) The observed rates could reflect a combination of steps, including the oxidation step-i.e., the oxidation step is only partially masked. Thus, a percentage of the relative difference in rates may still be observed. Finally, a combination of these factors could lead to the observed results.
It is also surprising that a purely electronic model can account for the differences in the rates of biotransformation. Previous studies by Jones (37) showed that the interchange of different orientations of xylene inside cytochrome P450 active site is fast. However, for bulky molecules, such as benzo-[a]pyrene and nicotine (38) , the spatial interaction between the substrate and the apoprotein becomes significant and steric factors, in addition to electronic factors, influence the rate. Lipophilicity is a common parameter used in structureactivity relationships (39, 40) . CYPs, in general, prefer lipophilic substrates. The compounds we selected for study are all relatively lipophilic, and the possibility that lipophilicity plays a role must be considered, but electronic factors were shown to be the major determinants of rates.
In conclusion, we present a validated model that predicts rates of halogenated alkane metabolism in vitro and in vivo in humans and in rodents. These results provide a strategic tool in the design of safer halogenated alkanes. Furthermore, the ability to predict human metabolic rates provides a tool to predict the potential toxicity of compounds that cannot be tested in humans. This model may be important in decreasing the cost of chemical development and in the design of safer chemicals. Integration of this model into the process of chemical discovery and development and into the regulatory review process of existing chemicals may also decrease the costs of chemical development and result in the design of safer chemicals.
